Sign in

CIK 0001279704 · Non-accelerated filer<br>Smaller reporting company

Cellectar Biosciences, Inc.

Sign in to watch
Ticker
CLRB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
043321804
Phone
(608) 441-8120
Business address
100 CAMPUS DRIVE, FLORHAM PARK, NJ, 07932
Former names
NOVELOS THERAPEUTICS, INC., COMMON HORIZONS INC
  1. 4 Open-market sale 10% owner sold 100,000 shares at an average $0.69 ($69,019)
  2. 4 Open-market sale 10% owner sold 82,847 shares at $0.69 ($57,405)
  3. 4 Open-market sale 10% owner sold 367,966 shares at an average $0.73 ($269,044)
  4. 4 Open-market sale 10% owner sold 7,938 shares at $0.90 ($7,181)
  5. 4 Open-market sale 10% owner sold 27,621 shares at an average $0.92 ($25,310)
  6. 4 Open-market sale 10% owner sold 71,225 shares at an average $0.87 ($61,881)
  7. 4 Open-market sale 10% owner sold 44,965 shares at $0.82 ($37,065)
  8. 4 Open-market sale 10% owner sold 50,950 shares at an average $1.06 ($54,182)
  9. 4 Open-market sale 10% owner sold 42,110 shares at $1.04 ($43,815)
  10. 4 Open-market sale 10% owner sold 4,378 shares at $1.20 ($5,265)
  11. 4 Open-market sale 10% owner sold 173,802 shares at an average $1.24 ($214,749)
  12. 4 Open-market buy President and CEO bought 1,000 shares at $1.30 ($1,302)
  13. 4 Open-market buy President and CEO bought 1,000 shares at $1.16 ($1,159)
  14. 4 Open-market sale 10% owner sold 96,806 shares at an average $1.17 ($113,336)
  15. 4 Open-market buy President and CEO bought 4,000 shares at an average $1.45 ($5,790)
  16. 4 Open-market sale 10% owner sold 99 shares at $2.00 ($198)
  17. 4 Open-market sale 10% owner sold 8,866 shares at $2.00 ($17,732)
  18. 4 Open-market sale 10% owner sold 2,554 shares at $2.00 ($5,108)
  19. 4 Open-market sale 10% owner sold 7,500 shares at an average $2.04 ($15,303)
  20. 4 Open-market sale 10% owner sold 27,940 shares at an average $2.05 ($57,174)

Page 9 of 11 · 211 filings